Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

EXPLOration of Processes Involved in Dissociative Identity Disorder (DID)

NCT07663890 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2026-06-04
Last updated
2026-06-26

Condition(s) studied

Dissociative Identity Disorder (DID)

Investigational drug(s) / intervention(s)

Questionnaire and Physical ExamInterview

Questionnaire and Physical Exam: 5 standardized assessment tools measuring, respectively, dissociation (sDIS-Q; Vancappel, Chkili, et al., 2025), beliefs about dissociation (DSB; Vancappel et al., 2023), knowledge and skills related to dissociation (KADS; Vancappel, Chami, et al., 2025), psychotrauma (Ashbaugh et al., 2016), and dissociation simulation.

Interview: qualitative interview with the therapist they are already seeing

Study summary

Dissociative Identity Disorder (DID) is a psychological condition in which a person may feel as though they have multiple distinct personalities or identities. Today, this disorder is being discussed more and more, particularly among young people, partly due to its visibility on social media. However, researchers have observed that some individuals may mimic or exaggerate the symptoms, which makes it more difficult to understand the disorder.

The goal of this study is therefore to better understand:

* in which situations these identity shifts occur
* what people feel at that moment
* and what happens next To do this, researchers will interview approximately 60 people, some with a diagnosed DID and others exhibiting simulated symptoms.

Participants will complete questionnaires and take part in an interview. The researchers will analyze:

* the situations that trigger the changes
* the associated thoughts and emotions
* the behaviors
* the consequences of these episodes

The ultimate goal is to better understand this disorder in order to:

* improve care
* and better distinguish between genuine cases and feigned ones

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Individuals who report having Dissociative Identity Disorder (DID) * At least 18 years old * Currently receiving treatment from a therapist (psychologist or psychiatrist) Exclusion Criteria: * Individuals under guardianship or court-ordered protection

Primary outcome measure(s)

  • Dissociative symptoms — baseline
    Questionnaire
  • Beliefs about dissociation — baseline
    Questionnaire
  • Skills and knowledge regarding dissociation — baseline
    Questionnaire
  • Psychotraumatic symptoms — baseline
    Questionnaire
  • How the TDI Works — baseline
    Qualitative interview
  • Simulation — baseline
    Qualitative interview
  • Dissociative symptoms — baseline
    Qualitative interview

Trial sites (4)

FacilityCityRegionStatus
Sophie Marek's Practice Carvin France Recruiting
Online Consultation Cabinet Chambray-lès-Tours France Recruiting
Online Consultation Cabinet - Alexis VANCAPPEL, Lille France Recruiting
Centre Régional du Psychotraumatisme Tours France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07663890 on ClinicalTrials.gov ↗ ← All trials in France